Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Hemopathy”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Not applicableEnded earlyNCT02999152
What this trial is testing

Validation of Radio-induced Damage Biomarkers

Who this might be right for
Bone MetastasisMalignant Hemopathy
Centre Hospitalier Universitaire de Saint Etienne 16
Not applicableActive Not RecruitingNCT03965429
What this trial is testing

Immunological Follow-up After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Malignant Hemopathy
Institut Paoli-Calmettes 1,020
Not applicableUnknownNCT06894381
What this trial is testing

Characteristics and Results of Patients Treated by Therapeutic Intensification

Who this might be right for
Malignant Hemopathy
University Hospital, Strasbourg, France 24
Not applicableNot Yet RecruitingNCT05602168
What this trial is testing

Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment Resistance

Who this might be right for
Hematologic Cancer
Institut Paoli-Calmettes 400
Large-scale testing (Phase 3)UnknownNCT01955772
What this trial is testing

Randomized, Prospective, Multicenter Study to Compare Enteral Nutrition to Parenteral Nutrition as Feeding Support in Patients Presenting Malignant Hemopathy Who Underwent an Allogeneic Hematopoietic Stem Cell Transplantation.

Who this might be right for
Myeloablative Allo-SCT
University Hospital, Clermont-Ferrand 240
Not applicableLooking for participantsNCT04517656
What this trial is testing

Biomarkers Impact Evaluation on the Post-transplant Immune Response After Allografting of Hematopoietic Stem Cells

Who this might be right for
Malignant Hemopathy
Centre Hospitalier Universitaire de Saint Etienne 40
Not applicableStudy completedNCT04390126
What this trial is testing

COVID-19 Related Lockdown Effects On Chronic Diseases

Who this might be right for
Chronic Coronary SyndromeHeart FailureAMD and Macular Edema+5 more
Centre Hospitalier Universitaire Dijon 1,343
Post-approval studies (Phase 4)Ended earlyNCT00190463
What this trial is testing

Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia

Who this might be right for
Malignant HemopathyDuration of Neutropenia Following Chemotherapy > 10 Days
Assistance Publique - Hôpitaux de Paris 300
Not applicableLooking for participantsNCT06262789
What this trial is testing

RAT-HEMATO : Return to Work After Malignant Hemopathy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma
University Hospital, Angers 264
Not applicableStudy completedNCT01574235
What this trial is testing

Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents

Who this might be right for
Solid TumorsMalignant HemopathyChemotherapy-induced Febrile Neutropenia (FN)
Hospira, now a wholly owned subsidiary of Pfizer 2,114
Not applicableStudy completedNCT06455553
What this trial is testing

Interpretability of the Quantra® Viscoelastic Test in Patients With Haematological Malignancies With Profound Thrombocytopenia Below 50x10 G/L.

Who this might be right for
Hematologic MalignanciesThrombopenia
Centre Hospitalier Annecy Genevois 48